Epizyme Inc (EPZM.OQ)

EPZM.OQ on NASDAQ Stock Exchange Global Select Market

24.01USD
4 Mar 2015
Change (% chg)

-- (--)
Prev Close
$24.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
101,177
52-wk High
$40.98
52-wk Low
$16.54

EPZM.OQ

Chart for EPZM.OQ

About

Epizyme, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. The Company systematically identify the genetic alterations that create cancer causing genes, called oncogenes, select patients in whom the... (more)

Overall

Beta: --
Market Cap(Mil.): $820.26
Shares Outstanding(Mil.): 34.16
Dividend: --
Yield (%): --

Financials

  EPZM.OQ Industry Sector
P/E (TTM): -- 175.69 40.21
EPS (TTM): -0.65 -- --
ROI: -15.32 -2.61 16.34
ROE: -18.49 -4.39 17.27
Search Stocks

Competitors

  Price Chg
Eisai Co., Ltd (4523.T) ¥6,732 +449.00
Novartis AG (NOVN.VX) CHF95.90 +0.70
GlaxoSmithKline plc (GSK.L) 1,575.75p +10.50
Celgene Corporation (CELG.OQ) $119.57 --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks